Sarcopenia Therapeutic Pipeline Drugs and Companies Review H1 2015 Market Research Report at ReportsnReports.com

Share Article

ReportsnReports.com adds “Sarcopenia - Pipeline Review, H1 2015” to its store. The report provides an overview of the Sarcopenia’s therapeutic pipeline.

Sarcopenia Therapeutic Pipeline Drugs and Companies Review

Sarcopenia Therapeutic Pipeline Drugs and Companies Review

This report provides comprehensive information on the therapeutic development for Sarcopenia. Sarcopenia is a disease associated with the aging process. Sarcopenia is assumed to play a major role in the pathogenesis of frailty and functional mutilation that occurs with old age. Sarcopenia is ubiquitous, affecting 10 – 50% of people over 60 years of age. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report is available at http://www.reportsnreports.com/reports/328774-sarcopenia-pipeline-review-h1-2015.html .

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. It also reviews key players involved in the therapeutic development for candidiasis and special features on late-stage and discontinued projects.

Companies discussed in this Sarcopenia - Pipeline Review, H1 2015 report include Calzada Limited, Cytokinetics, Inc., GlaxoSmithKline plc, Myos Corporation, Neurotune AG, Novartis AG, PsiOxus Therapeutics, Ltd., Regeneron Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=328774 . (This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases:

  • Mar 13, 2012: Calzada Announces Positive Results Of AOD9604 In Cartilage And Muscle Repair Models
  • Dec 14, 2011: Calzada Announces New Applications For AOD9604
  • Dec 08, 2011: PsiOxus Therapeutics To Present Data On MT-102 At Cachexia Conference
  • Aug 02, 2011: Researchers At Columbia University Discover New Drug For Sarcopenia
  • Dec 16, 2010: Myotec Therapeutics Completes Merger With Hybrid BioSystems To Form PsiOxus Therapeutics

Table of Contents

List of Tables
Number of Products under Development for Sarcopenia, H1 2015 8
Number of Products under Development for Sarcopenia - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Sarcopenia - Pipeline by Calzada Limited, H1 2015 16
Sarcopenia - Pipeline by Cytokinetics, Inc., H1 2015 17
Sarcopenia - Pipeline by GlaxoSmithKline plc, H1 2015 18
Sarcopenia - Pipeline by Myos Corporation, H1 2015 19
Sarcopenia - Pipeline by Neurotune AG, H1 2015 20
Sarcopenia - Pipeline by Novartis AG, H1 2015 21
Sarcopenia - Pipeline by PsiOxus Therapeutics, Ltd., H1 2015 22
Sarcopenia - Pipeline by Regeneron Pharmaceuticals, Inc., H1 2015 23
Sarcopenia - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H1 2015 24
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Stage and Target, H1 2015 27
Number of Products by Stage and Mechanism of Action, H1 2015 29
Number of Products by Stage and Route of Administration, H1 2015 31
Number of Products by Stage and Molecule Type, H1 2015 33
Sarcopenia Therapeutics - Recent Pipeline Updates, H1 2015 50
Sarcopenia - Dormant Projects, H1 2015 53
Sarcopenia - Discontinued Products, H1 2015 54

List of Figures
Number of Products under Development for Sarcopenia, H1 2015 8
Number of Products under Development for Sarcopenia - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Top 10 Targets, H1 2015 26
Number of Products by Stage and Top 10 Targets, H1 2015 27
Number of Products by Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 29
Number of Products by Top 10 Routes of Administration, H1 2015 30
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 31
Number of Products by Top 10 Molecule Types, H1 2015 32
Number of Products by Stage and Top 10 Molecule Types, H1 2015 33

Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offers customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@chinamrreport
Follow >
Market Reports China
Like >
Follow us on
Visit website